- Home
- GORV vs OVID Comparison
GORV vs OVID Comparison
Compare GORV & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GORV
- OVID
- Stock Information
- Founded
- GORV 1976
- OVID 2014
- Country
- GORV United States
- OVID United States
- Employees
- GORV N/A
- OVID N/A
- Industry
- GORV Retail-Auto Dealers and Gas Stations
- OVID Biotechnology: Pharmaceutical Preparations
- Sector
- GORV Consumer Discretionary
- OVID Health Care
- Exchange
- GORV Nasdaq
- OVID Nasdaq
- Market Cap
- GORV 25.3M
- OVID 20.6M
- IPO Year
- GORV 2015
- OVID 2017
- Fundamental
- Price
- GORV $4.32
- OVID $0.55
- Analyst Decision
- GORV Hold
- OVID Strong Buy
- Analyst Count
- GORV 2
- OVID 4
- Target Price
- GORV $60.00
- OVID $3.13
- AVG Volume (30 Days)
- GORV 38.4K
- OVID 2.4M
- Earning Date
- GORV 08-19-2025
- OVID 08-19-2025
- Dividend Yield
- GORV N/A
- OVID N/A
- EPS Growth
- GORV N/A
- OVID N/A
- EPS
- GORV N/A
- OVID N/A
- Revenue
- GORV $767,257,000.00
- OVID $548,000.00
- Revenue This Year
- GORV $15.65
- OVID N/A
- Revenue Next Year
- GORV $20.54
- OVID $5.32
- P/E Ratio
- GORV N/A
- OVID N/A
- Revenue Growth
- GORV N/A
- OVID 15.61
- 52 Week Low
- GORV $3.83
- OVID $0.24
- 52 Week High
- GORV $77.07
- OVID $1.47
- Technical
- Relative Strength Index (RSI)
- GORV 28.97
- OVID 59.24
- Support Level
- GORV $3.83
- OVID $0.48
- Resistance Level
- GORV $5.49
- OVID $0.73
- Average True Range (ATR)
- GORV 0.50
- OVID 0.05
- MACD
- GORV -0.18
- OVID -0.01
- Stochastic Oscillator
- GORV 5.06
- OVID 29.76
About GORV Lazydays Holdings Inc.
Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.
About OVID Ovid Therapeutics Inc.
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.